How differentiated care supports “Tx all” and Dr

Slides:



Advertisements
Similar presentations
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Advertisements

Contribution of Economics to Operational Research for Evaluation of Scaling Up Access to HIV Care & Treatment in Developing Countries Presentation by Pr.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
M. Bemelmans, S. Baert, E. Goemaere, L. Wilkinson, M. Vandendyck, G. Van Cutsem, C. Silva, S. Perry, E Szumilin, R. Gerstenhaber, L. Kalenga, M. Biot,
Dr. Yogan Pillay Deputy Director General National Department of Health, South Africa Monday 1 July 2013 OPERATIONAL AND PROGRAMMATIC CONSIDERATIONS IN.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Module 2: Learning Objectives
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
World Health Organization. Task shifting for integrated and decentralized HIV treatment Eyerusalem Negussie, Margaret Streeten, Brian Pazvakavambwa, Amitabh.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Progress of implementation of the Caribbean Regional Strategic Framework Morris Edwards Head, Strategy & Resourcing Division Pancap Coordinating.
4 th AMTP UA Progress Report 5 th AMTP Outcomes Framework VISION The spread of HIV is halted in the Philippines OUTCOMES Persons at-risk, vulnerable,
Dr. Prosper Chonzi MBChB, MPH, MBA Director of Health Harare City 30 November 2015 Harare – A Fast Track City.
Decentralization of Option B+ services and implications for task shifting Dr Franck Fwamba N’kulu National AIDS & STI Control Programme Democratic Republic.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Expert Patients and AIDS Ministry of HealthMSF-OCB Mozambique CDC From Field Operational Research to National Roll Out of CASG in Mozambique.
ICASA |1 | LEARNING FROM “B+” IMPLICATIONS FOR IMPLEMENTING “TREAT ALL” Dr. Gottfried Hirnschall WHO, Geneva ICASA Harare, December 2015.
#AIDS2016 ASSESSMENT OF THE WORLD HEALTH ORGANIZATION EARLY WARNING INDICATORS OF HIV DRUG RESISTANCE IN NAMIBIA FOR PUBLIC HEALTH ACTION,
#AIDS2016 Safer conception for men and women living with HIV and their partners Key issues and considerations for widespread implementation.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Joseph Kibachio4, William Etienne1, Saar Baert5, Helen Bygrave5
The CQUIN Learning Network: Partnering to Advance Differentiated Care
New WHO Guidelines on Person centred monitoring
Scaling up Access to HIV treatment What can we learn for NCDs?
Differentiated service delivery for ART
Lynne Wilkinson IAS.
Dr. Tsitsi Apollo Ministry of Health and Child Care, Zimbabwe
Module 4: Engaging KPs with HIV and SRH Services
Differentiated Monitoring & Evaluation
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Differentiated Care across the Cascade: Experiences from Zimbabwe
TITLE Differentiated Care for People who inject Drugs, Men who have sex with men, Sex workers, Transgender people, Prisoners and other people living in.
26 July 2017 Catherine Barker, Arin Dutta, Kate Klein
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
World Health Organization
Differentiated Service Delivery: Innovating for Impact
2017 Key Considerations for adolescents and children & Key populations
Continuum of HIV Care, Treatment, and Prevention
PMTCT Prongs 1 & 2 and the repositioning of Family Planning ICASA 2011
Dr. Roger Teck - MSF WHO Satellite Meeting ICASA Harare
Using HIV cohort collaboration data to evaluate and inform policy and practice Mary-Ann Davies.
Country policies to enable Differentiated Care: Four country examples
Closing the Treatment Gap of Children Living with HIV
WHO, UNICEF, UNFPA, UNESCO & GNP+
The Last Mile to EMTCT: Are we there yet?
Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges Tamrat Assefa1, Zenebe Melaku1,
The use of cotrimoxazole prophylaxis in the context of HIV infection
Community–led qualitative research
Advanced HIV: a WHO perspective
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Charles Gilks HIV Department, WHO
National Department of Health: South Africa
ANTIRETROVIRAL TREATMENT IN RESOURCE-LIMITED SETTINGS: PROGRESS & CHALLENGES IN SOUTH AFRICA YOGAN PILLAY DEPARTMENT OF HEALTH, SOUTH AFRICA IAS, 2014.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
KATUREEBE CORDELIA, MBchB, MMED Pead
CQUIN Call to Action Peter Preko MB, ChB Project Director, CQUIN
Jessica Justman, MD Senior Technical Director ICAP at Columbia
Update on global progress in ART
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

How differentiated care supports “Tx all” and 90-90-90 Dr How differentiated care supports “Tx all” and 90-90-90 Dr. Gottfried Hirnschall Director, WHO HIV Department

Closer to home: MSF pioneered community ARV models World Health Organization 11 April 2018 Closer to home: MSF pioneered community ARV models MSF Photo MSF

Much to do to achieving the 90 90 90 targets

Retention on ART 2009-2014 Retention is a major challenge Data from 6 regions 41 countries 304,000 patients Retention worse for Men Children & adolescents Retention is a major challenge Source: IeDEA-WHO 2015

Framework for Differentiated care WHO recognizes that “one size fits all “will not work as HIV programmes continue to expand Differentiated services allow for a public health approach that maximizes the benefit for PLHIV and for the health care system People presenting well People presenting with advanced HIV infection (CD4<200 cells) People who are stable on treatment People on ART with complex problems

Service Delivery Approaches to Treat All

World Health Organization Differentiated care improves outcomes for patients and health services and health care worker 11 April 2018 These models have improved retention in S Africa and Mozambique; and allowed decanting from over crowded clinics to communities that have established rapport Adapted from MSF

Reducing the frequency of clinic visits and ARV pickup World Health Organization Reducing the frequency of clinic visits and ARV pickup 11 April 2018 For patients stable on ART: Less frequent clinic visits: 3-6 months Less frequent medication pick up: 3-6 months Trained and supervised lay providers can distribute ARV in community settings for children, adolescents and adults living with HIV Background Information: People with advanced disease are defined as those presenting to care with a CD4 count below 200 cells/mm3 or WHO disease stage 3 and 4. Stable patients are defined as those who have received ART for at least one year and have no adverse drug reactions that require regular monitoring, no current illnesses or pregnancy, are not currently breastfeeding, have good understanding of lifelong adherence and evidence of treatment success (i.e. two consecutive viral load measures below 1000 copies/ml).  In the absence of viral load monitoring, rising CD4 counts or CD4 counts above 200 cells/mm3, an objective adherence measure can be used to indicate treatment success. The definition for stable patients does not include pregnant women, as they also need attending maternal health services.

Integrated service delivery Integration with other services: HIV-Associated TB integration ART in MNCH care services Comprehensive services for people who inject drugs STIs and family planning services -

Adolescent Service Delivery Adolescent friendly health services approaches should be implemented in HIV services to ensure engagement and improved outcomes *New* Standards

WHO Global strategy of people-centred and integrated health services

Perspectives of people living with HIV World Health Organization Perspectives of people living with HIV 11 April 2018 People centred care = easily accessible, good quality, humane, respectful and dignified. HIV should be normalised and families and communities should be involved in provision of care. Need to have a partnership between provider and recipient of care. Barriers and challenges relate to health system access, stigma, discrimination and attitudes. GNP+ Bushee J, Hows J, de Haas B, Beanland R Survey on the quality of HIV care experienced by people living with and affected by HIV around the world 2015 (in press).

Using viral load to support differentiated care is cost effective World Health Organization Using viral load to support differentiated care is cost effective 11 April 2018 Nature, 2015

Adherence clubs in South Africa more cost effective than standard of care Standard care Cost (patient year) $300 ✔ $374 ✔ Retention (12 months) 98% ✔ 95% ✔ Viral suppression 99% ✔ 97% ✔ Bango et al, TMIH 2016

“Differentiated Care” as a key element of the New ARV Guidelines Adopting the “Treat all” recommendation is central to achieving 90-90-90 WHO guidelines put forward 20 new service delivery recommendations that enable differentiated care Potential to improve outcomes and service efficiency One size does not fit all – different approaches to service delivery according to epidemic context A flexible M&E system from clinic to community is required to ensure quality and safety

Acknowledgements MSF Andrew Philipps Meg Doherty Nathan Ford Chery Johnson Acknowledgements